Removing atherosclerotic plaque created using high cholesterol diet in rabbit using ultrasound

Journal of Therapeutic Ultrasound

Nicos Mylonas¹  Christos Christofi³  Christakis Damianou² 

[1]Computer Science Department, Frederick Research Center, Limassol, Cyprus

[2]R&D Department, MEDSONIC, LTD, Limassol, Cyprus

[3]Electrical Engineering Department, Cyprus University of Technology, Limassol, Cyprus

关键词: Pulse;    Plaque;    Atherosclerotic;    Ultrasound;   

Others  :  1132825
DOI  :  10.1186/s40349-015-0025-8

【 摘 要 】

Background

The aim of the proposed study was to conduct a feasibility study using a flat rectangular (3 × 10 mm²) transducer operating at 5 MHz for removing atherosclerotic plaque in an in vivo model. The proposed method can be used in the future for treating atherosclerotic plaques in humans.

Methods and results

The plaque in the rabbits was created using high cholesterol diet for 4 months. The amount of plaque removed was studied as a function of intensity, with a fixed pulse repetition frequency (PRF), and duty factor (DF).

Conclusions

The amount of plaque removed is directly related to the acoustic intensity. It was found that the presence of bubbles accelerates the removal of plaque. In order to ensure that pure mechanical mode ultrasound was used, the intensity used does not produce temperatures that exceed 1°C.

【 授权许可】

   
2015 Damianou et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】

• [1]Wagenknecht L, Wasserman B, Chambless L, Coresh J, Folsom A, Mosley T, et al.: Correlates of carotid plaque presence and composition as measured by magnetic resonance imaging: the Atherosclerosis Risk in Communities (ARIC) Study. Wagenknecht, risk factors & MRI measured carotid plaque. Circ Cardiovasc Imaging 2009, 2(4):314-22.
• [2]Romer TJ, Brennan JF, Fitzmaurice M, Feldstein ML, Deinum G, Myles JL, et al.: A rotational ablation tool for calcified atherosclerotic plaque removal. Biomed Microdevices. 1998, 97:8.
• [3]Insull W: The pathology of atherosclerosis: plaque development and plaque responses to medical treatment. Am J Med 2009, 122(1):S3-14.
• [4]Mercando AD, Lai HM, Aronow WS, Kalen P, Desai HV, Gandhi K, et al.: Reduction in atherosclerotic events: a retrospective study in an outpatient cardiology practice. Arch Med Sci 2012, 8(1):57-62.
• [5]Weintraub WS, Mauldin PD, Becker E, Kosinski AS, King SB: A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease. Results from the Emory Angioplasty Versus Surgery Trial (EAST). Circulation 1995, 92(10):2831-40.
• [6]Lan C, Chen SY, Chiu SF, Hsu CJ, Lai JS, Kuan PL: Poor functional recovery may indicate restenosis in patients after coronary angioplasty. Arch Phys Med Rehabil 2003, 84(7):1023-7.
• [7]Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, et al.: Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv 2011, 4(5):495-504.
• [8]Boyle CJ, Lennon AB, Prendergast PJ: In silico prediction of the mechanobiological response of arterial tissue: application to angioplasty and stenting. J Biomed Eng 2011, 133(8):081001.
• [9]Kossovsky N: Intravascular stents after transluminal angioplasty. N Engl J Med 1987, 317(13):836-7.
• [10]Takebayashi H, Haruta S, Kohno H, Ichinose H, Taniguchi M, Shimakura T, et al.: Immediate and 3-month follow-up outcome after cutting balloon angioplasty for bifurcation lesions. J Interv Cardiol 2004, 17(1):1-7.
• [11]Bergersen LJ, Perry SB, Lock JE: Effect of cutting balloon angioplasty on resistant pulmonary artery stenosis. Am J Cardiol 2003, 91(2):185-9.
• [12]Unterberg C, Buchwald AB, Barath P, Schmidt T, Kreuzer H, Wiegand V: Cutting balloon coronary angioplasty-initial clinical experience. Clin Cardiol 1993, 16(9):660-4.
• [13]Safian RD, Grines CL, May MA, Lichtenberg A, Juran N, Schreiber TL, et al.: Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts. Circulation 1994, 89(1):302-12.
• [14]Mangiacapra F, Heyndrickx GR, Puymirat E, Peace AJ, Wijns W, De Bruyne B, et al.: Comparison of drug-eluting versus bare-metal stents after rotational atherectomy for the treatment of calcified coronary lesions. Int J Cardiol 2012, 154(3):373-6.
• [15]Forouzannia SK, Abdollahi MH, Mirhosseini SJ, Hosseini H, Moshtaghion SH, Golzar A, et al.: Clinical outcome and cost in patients with off-pump vs. on-pump coronary artery bypass surgery. Acta Med Iran 2011, 49(7):414-9.
• [16]Lee EJ, Choi KH, Ryu JS, Jeon SB, Lee SW, Park SW, et al.: Stroke risk after coronary artery bypass graft surgery and extent of cerebral artery atherosclerosis. J Am Coll Cardiol 2011, 57(18):1811-8.
• [17]Warren JA, Jordan WD Jr, Heudebert GR, Whitley D, Wirthlin DJ: Determining patient preference for treatment of extracranial carotid artery stenosis: carotid angioplasty and stenting versus carotid endarterectomy. Ann Vasc Surg 2003, 17(1):15-21.
• [18]Hollenbeak CS, Bowman AR, Harbaugh RE, Casale PN, Han D: The impact of surgical specialty on outcomes for carotid endarterectomy. J Surg Res 2010, 159(1):595-602.
• [19]McDonald RJ, Cloft HJ, Kallmes DF: Intracranial hemorrhage is much more common after carotid stenting than after endarterectomy: evidence from the national inpatient sample. Stroke 2011, 42(10):2782-7.
• [20]Gelet A, Chapelon JY, Margonari J, Theillère Y, Gorry F, Souchon R, et al.: High intensity focused ultrasound experimentation on human benign prostatic hypertrophy. Eur Urol 1993, 23(1):44-7.
• [21]Chaussy C, Thuroff S: The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep 2003, 4(3):248-52.
• [22]Madersbacher S, Marberger M: High-energy shockwaves and extracorporeal high-intensity focused ultrasound. J Endourol 2003, 17(8):667-72.
• [23]Saleh KY, Smith NB: A 63 element 1.75 dimensional ultrasound phased array for the treatment of benign prostatic hyperplasia. Biomed Eng Online 2005, 4(1):39. BioMed Central Full Text
• [24]Yehezkeli O, Freundlich D, Magen N, Marantz C, Medan Y, Vitek S, et al. INSIGHTEC-TXSONICSLTD, assignee. Mechanical positioner for MRI guided ultrasound therapy system WO0209812, Inventors Word intellectual property organization 2002.
• [25]Stewart EA, Gedroyc W, Tempany CM, Quade B, Inbar Y, Ehrenstein T, et al.: Focused ultrasound treatment of uterine fibroids: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol 2003, 189(1):48-54.
• [26]Tempany CM, Stewart EA, McDannold N, Quade B, Jolesz F, Hynynen K: MRI guided focused ultrasound surgery (FUS) of uterine leiomyomas: a feasibility study. Radiology 2003, 227(3):897-905.
• [27]Stewart EA, Rabinovici J, Tempany C, Inbar Y, Regan L, Gostout B, et al.: Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 2006, 85(1):22-9.
• [28]Kim HS, Baik JH, Pham LD, Jacobs MA: MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata long-term outcomes. Acad Radiol 2011, 18(8):970-6.
• [29]Zini C, Elisabeth H, Stephen T, Alessandro N, Carlo C, Aytekin O: Ultrasound and MR-guided focused ultrasound surgery for prostate cancer. World J Radiol 2012, 4(6):247-52.
• [30]Napoli A, Anzidei M, De Nunzio C, Cartocci G, Panebianco V, De Dominicis C, et al.: Real-time magnetic resonance–guided high-intensity focused ultrasound focal therapy for localised prostate cancer: preliminary experience. Eur Urol 2013, 63(2):395-8.
• [31]Napoli A, Anzidei M, Marincola BC, Brachetti G, Ciolina F, Cartocci G, et al.: Primary pain palliation and local tumor control in bone metastases treated with magnetic resonance-guided focused ultrasound. Invest Radiol 2013, 48(6):351-8.
• [32]Lee JE, Yoon SW, Kim KA, Lee JT, Shay L, Lee KS: Successful use of magnetic resonance-guided focused ultrasound surgery for long-term pain palliation in a patient suffering from metastatic bone tumor. J Korean Soc Radiol 2011, 65(2):133-8.
• [33]Catane R, Beck A, Inbar Y, Rabin T, Shabshin N, Hengst S, et al.: MR-guided focused ultrasound surgery (MRgFUS) for the palliation of pain in patients with bone metastases-preliminary clinical experience. Ann Oncol 2006, 18(1):163-7.
• [34]McDannold N, Clement G, Black P, Jolesz F, Hynynen K: Transcranial MRI-guided focused ultrasound surgery of brain tumors: Initial findings in three patients. Neurosurgery 2010, 66(2):323-32.
• [35]Dorenberg EJ, Courivaud F, Ring E, Hald K, Jakobsen JA, Fosse E, et al.: Volumetric ablation of uterine fibroids using Sonalleve high-intensity focused ultrasound in a 3 Tesla scanner—first clinical assessment. Minim Invasive Ther 2013, 22(2):73-9.
• [36]Wu F, Chen WZ, Bai J, Zou JZ, Wang ZL, Zhu H, et al.: Pathological changes in malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol 2001, 27(8):1099-106.
• [37]Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, et al.: Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology 2005, 235(2):659-67.
• [38]Li CX, Xu GL, Jiang ZY, Li JJ, Luo GY, Shan HB, et al.: Analysis of clinical effect of high-intensity focused ultrasound on liver cancer. World J Gastroenterol 2004, 10(15):2201-4.
• [39]Wu F, Wang ZB, Chen WZ, Zhu H, Bai J, Zou JZ, et al.: Extracorporeal high intensity focused ultrasound ablation in the treatment of patients with large hepatocellular carcinoma. Ann Surg Oncol 2004, 11(12):1061-9.
• [40]Shehata IA, Ballard JR, Casper AJ, Liu D, Mitchell T, Ebbini ES: Feasibility of targeting atherosclerotic plaques by high-intensity-focused ultrasound: an in vivo study. J Vasc Interv Radiol 2013, 24(12):1880-7.
• [41]Hur SJ, Min B, Nam KC, Lee EJ, Ahn DU: Effect of dietary cholesterol and cholesterol oxides on blood cholesterol, lipids, and the development of atherosclerosis in rabbits. Int J Mol Sci 2013, 14(6):12593-606.
• [42]Hosseini M, Asgary S: Effects of dietary supplementation with ghee, hydrogenated oil, or olive oil on lipid profile and fatty streak formation in rabbits. ARYA Atherosclerosis 2012, 8(3):119-24.
• [43]Davidson F: Ultrasonic power balances. In Output measurements for medical ultrasound. Edited by Preston RC. Springer, New York; 1991:75-90.
• [44]Kim MH, Kim HJ, Kim NN, Yoon HS, Ahn SH: A rotational ablation tool for calcified atherosclerotic plaque removal. Biomed Microdevices 2011, 13(6):963-71.
• [45]Pizzulli L, Köhler U, Manz M, Lüderitz B: Mechanical dilatation rather than plaque removal as major mechanism of transluminal coronary extraction atherectomy. J Interv Cardiol 1993, 6(1):31-9.
• [46]Damianou C, Hadjisavvas V, Ioannides K: In vitro and in vivo evaluation of an MRI-guided focused ultrasound system for dissolving clots in combination with thrombolytic drugs. J Stroke Cerebrovasc Dis 2014, 23(7):1956-64.